Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Feb. 4, 2014

View Archived Issues

Washington roundup: VAD readmissions hold steady despite rising COPD, atrial fib

FDA clears PillCam COLON for following incomplete colonoscopy

Grants roundup: Tasso simplifies blood sampling, secures $2.3 million in funding

Financings roundup: MELA Sciences reports details of its recent private placement

Agreements/contracts: Definiens extends testing collaboration with Clarient

HIT roundup: Telemedicine app helps prevent unnecessary CT scans in kids

Products

People in Places

MDD's Cardiology Extra

Deals roundup: Smith & Nephew in bid to acquire ArthroCare for $1.7 billion in cash

Smith & Nephew (S&N; London) reported the execution of a definitive agreement to acquire ArthroCare (Austin) for about $1.7 billion. Read More

Report from Europe: GI's EndoBarrier received into German reimbursement system

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...